Anti-Human Phosphatidylserine Recombinant Antibody (TAB-175)

CAT#: TAB-175

Recombinant monoclonal antibody to phosphatidylserine. It is a chimeric monoclonal antibody designed for the treatment of cancers and viral infections.

Specifications

  • Immunogen
  • Liposomes containing 70% phosphatidylserine and 30% phosphatidylglycerol.
  • Host Species
  • Mouse
  • Derivation
  • Chimeric (mouse/human)
  • Type
  • IgG1 - kappa
  • Specificity
  • Tested positive against native human antigen.
  • Species Reactivity
  • Human
  • Applications
  • Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, ICC and most other immunological methods.
  • MW
  • 145.3 kDa
  • Related Disease
  • Influenza

Product Property

  • Purity
  • >95.0% as determined by analysis by SDS-PAGE.
  • Storage
  • Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.

Target

  • Alternative Names
  • Bavituximab;648904-28-3;ch3G4;PGN401;Phosphatidylserine;PS;Ptd-L-Ser
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for TAB-175. Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression Rachel Adams
25.Apr,23
Excellent for Phosphatidylserine
The Anti-Human Phosphatidylserine Therapeutic Antibody (Bavituximab) has been excellent for our phosphatidylserine studies. Its quality is top-notch, providing clear and reliable results. This product has significantly improved the accuracy of our experiments and saved us a lot of troubleshooting time.
Breast cancer biomarkers at key points during disease progression Michael Clark
07.Aug,22
Effective and Dependable
We incorporated this antibody into our phosphatidylserine protocols, and it has been a great asset. The consistency and reliability are impressive, allowing for accurate and reproducible results. The reliable performance has made it an invaluable tool in our lab.
Breast cancer biomarkers at key points during disease progression Laura Harris
03.Jun,21
Consistent High-Quality Results
This antibody has proven to be consistent and high-quality in our phosphatidylserine procedures. The reproducible results have significantly improved our experiments, making it a crucial part of our research toolkit. The consistent performance has greatly enhanced our data quality.

Q&As

  1. Is the anti-Human Phosphatidylserine therapeutic antibody Bavituximab suitable for use in Western blotting?

    A: Yes, the anti-Human Phosphatidylserine therapeutic antibody Bavituximab (TAB-175) is suitable for use in Western blotting. It provides specific binding to phosphatidylserine, allowing for reliable detection in Western blot assays.

  2. What are the storage recommendations for the anti-Human Phosphatidylserine therapeutic antibody Bavituximab?

    A: The recommended storage condition for the anti-Human Phosphatidylserine therapeutic antibody Bavituximab (TAB-175) is at -20°C or lower. For short-term storage, it can be kept at 2-8°C. To ensure stability, avoid repeated freeze-thaw cycles.

  3. Can the anti-Human Phosphatidylserine therapeutic antibody Bavituximab be used in immunoprecipitation assays?

    A: Yes, the anti-Human Phosphatidylserine therapeutic antibody Bavituximab (TAB-175) can be used in immunoprecipitation assays. It provides specific binding to phosphatidylserine, enabling the successful precipitation of the target molecule from complex mixtures.

  4. Is the anti-Human Phosphatidylserine therapeutic antibody Bavituximab effective in ELISA applications?

    A: Yes, the anti-Human Phosphatidylserine therapeutic antibody Bavituximab (TAB-175) is effective in ELISA applications. It has been validated for use in such assays and provides reliable detection of phosphatidylserine.

  5. What is the optimal dilution for using the anti-Human Phosphatidylserine therapeutic antibody Bavituximab in immunofluorescence?

    A: The optimal dilution for using the anti-Human Phosphatidylserine therapeutic antibody Bavituximab (TAB-175) in immunofluorescence is typically 1:100 to 1:500. It is advisable to perform a dilution series to determine the best working concentration for your specific experimental conditions.

View the frequently asked questions answered by Creative Biolabs Support.

Citations

  1. Laggner, Maria, et al. "The secretome of irradiated peripheral blood mononuclear cells attenuates activation of mast cells and basophils." EBioMedicine 81 (2022). https://doi.org/10.1016/j.ebiom.2022.104093
    The study focused on the anti-allergic potential of the secretome of gamma-irradiated peripheral blood mononuclear cells (PBMCsec) in reducing the activation of mast cells and basophils, which are key players in allergic reactions. Researchers used both in vitro and in vivo models to investigate how PBMCsec influences mast cell degranulation and basophil activation, finding that PBMCsec effectively attenuates the activation of these immune cells. Specifically, topical application of PBMCsec on mouse ears significantly reduced tissue swelling caused by mast cell degranulation, while in vitro studies showed that PBMCsec inhibited mediator release from human dermal mast cells and basophils upon allergen stimulation. Transcriptomic analyses revealed that PBMCsec downregulates genes involved in immune cell activation and degranulation, underscoring its potential as an anti-allergic treatment.
    Creative Biolabs provided the anti-human phosphatidylserine antibody Bavituximab (Cat#: TAB-175) used in this study. This antibody was essential for the blocking experiments that aimed to determine the role of phosphatidylserine (PS) in PBMCsec-mediated inhibition of basophil activation. The use of Bavituximab helped to elucidate the mechanisms by which PBMCsec prevents immune cell degranulation, thereby supporting the identification of PS and other lipid species as the active components responsible for the anti-allergic effects observed.

Cite This Product

To accurately reference this product in your publication, please use the following citation information:

(Creative Biolabs Cat# TAB-175, RRID: AB_3111848)

Copy citation

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biosimilar Overview

Please refer to Bavituximab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Bavituximab.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "phosphatidylserine"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
AFC-TAB-175 Afuco™ Anti-Phosphatidylserine ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-175) FuncS, IF, Neut, ELISA, FC, IP ADCC enhanced antibody
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare